A significant public health milestone has been achieved by Hilleman Laboratories and its partner Bharat Biotech with the launch of HILLCHOL®, a breakthrough oral cholera vaccine. As a joint venture between MSD and Wellcome, Hilleman Laboratories is a first-of-its-kind vaccine development hub, dedicated to rapid end-to-end research and vaccine development for low- and middle-income countries. … Continue reading Breakthrough Oral Cholera Vaccine